Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2025 Earnings Call Transcript February 11, 2026 Viking Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.38 EPS, expectations were $-0.

Individual-level attribution modeling reveals that real-world semaglutide effectiveness is not a fixed property of the molecule, but an interaction between pharmacological exposure and modifiable care ...

Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to ...

Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, February 11 ...

Portree, the capital of the Isle of Skye, and Falmouth, on the southern tip of Cornwall, also feature on this exhaustive list ...

When we think about heat traveling through a material, we typically picture diffusive transport, a process that transfers ...

There are two schools of thought when it comes to teaching the backswing. Here's why Tom Patri likes taking a "chameleon" approach. The post There are 2 distinct ways to make a backswing. Which fits ...

Dr. Dan Thomson shares essential tips for injections, needle selection and syringe maintenance to ensure herd health and carcass quality.

Portree, the capital of the Isle of Skye, and Falmouth, on the southern tip of Cornwall, also feature on this exhaustive list ...